...
首页> 外文期刊>American pharmaceutical review >Potential Mycoplasma Contaminants: Inactivation during Production of Inactivated Egg-Based Viral Vaccines
【24h】

Potential Mycoplasma Contaminants: Inactivation during Production of Inactivated Egg-Based Viral Vaccines

机译:潜在的支原体污染物:灭活基于鸡蛋的病毒疫苗生产过程中的灭活

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mycoplasmas (the trivial name for Mollicutes) comprise the class of broadly distributed, wall less free living bacteria with one of the smallest known genomes supporting bacterial self replication [1]. While many mycoplasmas are commensals colonizing a wide range of plant, insect, reptilian, avian, mammalian, and human hosts, a number of mycoplasma species are pathogenic and cause disease in their natural hosts. Mycoplasmas, particularly species of the genera Mycoplasma and Acholeplasma, are also frequent contaminants of vaccine substrates, i.e., continuous cell lines, and less frequently, animal-derived tissues and primary cell cultures [2]. This presents a serious concern regarding the risk of mycoplasma contamination for research laboratories and commercial facilities developing and manufacturing cell-derived biological and pharmaceutical products.
机译:支原体(Mollicutes的小名)包括一类分布广泛,壁少的游离活细菌,其中最小的已知基因组之一支持细菌的自我复制[1]。虽然许多支原体在许多植物,昆虫,爬虫类,鸟类,哺乳动物和人类宿主中共生,但许多支原体却具有致病性并在其自然宿主中引起疾病​​。支原体,特别是支原体和无孢子体属的种,也是疫苗底物的常见污染物,即连续细胞系,而动物来源的组织和原代细胞培养物则较少[2]。对于研究实验室和商业机构开发和生产源自细胞的生物和药物产品的支原体污染风险,这引起了严重的关注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号